Literature DB >> 24970368

Sine oculis homeobox homolog 1 promotes DNA replication and cell proliferation in cervical cancer.

Dan Liu1, Xiao-Xue Zhang1, Bi-Xin Xi1, Dong-Yi Wan1, Li Li1, Jin Zhou1, Wei Wang2, Ding Ma1, Hui Wang1, Qing-Lei Gao1.   

Abstract

Malignant proliferation is the fundamental trait of tumor cells. The initiation of DNA replication represents a key process for cell proliferation, and has a marked impact on tumorigenesis and progression. Here we report that Sine oculis homeobox homolog 1 (SIX1) functions as a master regulator in DNA replication of cervical cancer cells. The expression of SIX1 was induced by the E7 oncoprotein of human papillomaviruses in cervical intraepithelial neoplasia and cervical cancer. The increase of SIX1 expression resulted in the upregulation of multiple genes related to the initiation of DNA replication, including the genes coding for the proteins in minichromosome maintenance complex (MCM2, MCM3, MCM6), DNA polymerase α-primase complex (POLA1, PRIM1, PRIM2), clamp loader (RFC3, RFC4, RFC5), DNA polymerase δ complex (POLD3) and DNA polymerase ε complex (POLE2). In line with this, the increase of SIX1 expression enhanced DNA synthesis, accelerated G1 to S phase progression, and promoted the proliferation of cervical cancer cells and the growth of cervical cancer. Consistently, knockdown of SIX1 could hamper DNA synthesis, slow down G1 to S phase progression, and suppress tumor cell proliferation and tumor growth. Importantly, SIX1 could more efficiently promote anchorage-independent cell growth. These results suggest that the increase of SIX1 expression could promote tumorigenesis, progression and invasive growth of cervical cancer by promoting DNA replication, and that targeting SIX1 may have significant therapeutic value in cervical cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24970368     DOI: 10.3892/ijo.2014.2510

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  21 in total

Review 1.  Multifaceted regulation and functions of replication factor C family in human cancers.

Authors:  Yanling Li; Sijie Gan; Lin Ren; Long Yuan; Junlan Liu; Wei Wang; Xiaoyu Wang; Yi Zhang; Jun Jiang; Fan Zhang; Xiaowei Qi
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells.

Authors:  Gero Doose; Andrea Haake; Stephan H Bernhart; Cristina López; Sujitha Duggimpudi; Franziska Wojciech; Anke K Bergmann; Arndt Borkhardt; Birgit Burkhardt; Alexander Claviez; Lora Dimitrova; Siegfried Haas; Jessica I Hoell; Michael Hummel; Dennis Karsch; Wolfram Klapper; Karsten Kleo; Helene Kretzmer; Markus Kreuz; Ralf Küppers; Chris Lawerenz; Dido Lenze; Markus Loeffler; Luisa Mantovani-Löffler; Peter Möller; German Ott; Julia Richter; Marius Rohde; Philip Rosenstiel; Andreas Rosenwald; Markus Schilhabel; Markus Schneider; Ingrid Scholz; Stephan Stilgenbauer; Hendrik G Stunnenberg; Monika Szczepanowski; Lorenz Trümper; Marc A Weniger; Steve Hoffmann; Reiner Siebert; Ingram Iaccarino
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

3.  Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis.

Authors:  Chao Guo; Ming Gong; Zhenling Li
Journal:  Cancer Manag Res       Date:  2020-07-16       Impact factor: 3.989

4.  Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.

Authors:  Xiaoxue Zhang; Dan Liu; Mengchen Li; Canhui Cao; Dongyi Wan; Bixin Xi; Wenqian Li; Jiahong Tan; Ji Wang; Zhongcai Wu; Ding Ma; Qinglei Gao
Journal:  J Hematol Oncol       Date:  2017-01-23       Impact factor: 17.388

5.  Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis.

Authors:  Claudia Cava; Gloria Bertoli; Antonio Colaprico; Catharina Olsen; Gianluca Bontempi; Isabella Castiglioni
Journal:  BMC Genomics       Date:  2018-01-06       Impact factor: 3.969

6.  Transcriptome profiling of cancer and normal tissues from cervical squamous cancer patients by deep sequencing.

Authors:  Wansong Lin; Mei Feng; Xiuhua Li; Peilin Zhong; Aihua Guo; Guilin Chen; Qin Xu; Yunbin Ye
Journal:  Mol Med Rep       Date:  2017-06-23       Impact factor: 2.952

7.  Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.

Authors:  Baojie Wu; Shuyi Xi
Journal:  BMC Cancer       Date:  2021-06-26       Impact factor: 4.430

8.  SIX1 coordinates with TGFβ signals to induce epithelial-mesenchymal transition in cervical cancer.

Authors:  Shu-Hua Sun; Dan Liu; Yun-Te Deng; Xiao-Xue Zhang; Dong-Yi Wan; Bi-Xin Xi; Wei Huang; Qian Chen; Meng-Chen Li; Ming-Wei Wang; Fei Yang; Ping Shu; Ke-Zhi Wu; Qing-Lei Gao
Journal:  Oncol Lett       Date:  2016-06-28       Impact factor: 2.967

9.  Potential new biomarkers for squamous carcinoma of the uterine cervix.

Authors:  Peter A van Dam; Christian Rolfo; Rossana Ruiz; Patrick Pauwels; Christophe Van Berckelaer; Xuan Bich Trinh; Jose Ferri Gandia; Johannes P Bogers; Steven Van Laere
Journal:  ESMO Open       Date:  2018-06-28

10.  Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.

Authors:  Chen-Fei Zhou; Jing Ma; Lei Huang; Hong-Yan Yi; Yan-Mei Zhang; Xiang-Guang Wu; Rui-Ming Yan; Li Liang; Mei Zhong; Yan-Hong Yu; Sha Wu; Wei Wang
Journal:  Oncogene       Date:  2018-09-25       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.